192 related articles for article (PubMed ID: 3190380)
1. Treatment of toxoplasmic encephalitis with intravenous clindamycin.
Dannemann BR; Israelski DM; Remington JS
Arch Intern Med; 1988 Nov; 148(11):2477-82. PubMed ID: 3190380
[TBL] [Abstract][Full Text] [Related]
2. Toxoplasmic encephalitis in patients with AIDS.
Israelski DM; Remington JS
Infect Dis Clin North Am; 1988 Jun; 2(2):429-45. PubMed ID: 3060527
[TBL] [Abstract][Full Text] [Related]
3. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team.
Luft BJ; Hafner R; Korzun AH; Leport C; Antoniskis D; Bosler EM; Bourland DD; Uttamchandani R; Fuhrer J; Jacobson J
N Engl J Med; 1993 Sep; 329(14):995-1000. PubMed ID: 8366923
[TBL] [Abstract][Full Text] [Related]
4. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.
Katlama C; Mouthon B; Gourdon D; Lapierre D; Rousseau F
AIDS; 1996 Sep; 10(10):1107-12. PubMed ID: 8874627
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy and safety of clindamycin plus pyrimethamine for induction and maintenance therapy of toxoplasmic encephalitis in AIDS.
Katlama C
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):189-91. PubMed ID: 2060527
[TBL] [Abstract][Full Text] [Related]
6. Sulfadiazine-induced crystalluria in AIDS patients with toxoplasma encephalitis.
Molina JM; Belenfant X; Doco-Lecompte T; Idatte JM; Modai J
AIDS; 1991 May; 5(5):587-9. PubMed ID: 1863412
[TBL] [Abstract][Full Text] [Related]
7. Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group.
Dannemann B; McCutchan JA; Israelski D; Antoniskis D; Leport C; Luft B; Nussbaum J; Clumeck N; Morlat P; Chiu J
Ann Intern Med; 1992 Jan; 116(1):33-43. PubMed ID: 1727093
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acute toxoplasmosis with intravenous clindamycin. The California Collaborative Treatment Group.
Dannemann BR; McCutchan JA; Israelski DM; Antoniskis D; Leport C; Luft BJ; Chiu J; Vildé JL; Nussbaum JN; Orellana M
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):193-5. PubMed ID: 2060529
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of patients with AIDS on maintenance therapy for toxoplasmosis.
Leport C; Tournerie C; Raguin G; Fernandez-Martin J; Niyongabo T; Vildé JL
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):191-3. PubMed ID: 2060528
[TBL] [Abstract][Full Text] [Related]
10. Adverse cutaneous reactions to pyrimethamine/sulfadiazine and pyrimethamine/clindamycin in patients with AIDS and toxoplasmic encephalitis.
Caumes E; Bocquet H; Guermonprez G; Rogeaux O; Bricaire F; Katlama C; Gentilini M
Clin Infect Dis; 1995 Sep; 21(3):656-8. PubMed ID: 8527561
[TBL] [Abstract][Full Text] [Related]
11. Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039.
Chirgwin K; Hafner R; Leport C; Remington J; Andersen J; Bosler EM; Roque C; Rajicic N; McAuliffe V; Morlat P; Jayaweera DT; Vilde JL; Luft BJ
Clin Infect Dis; 2002 May; 34(9):1243-50. PubMed ID: 11941551
[TBL] [Abstract][Full Text] [Related]
12. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine.
Foppa CU; Bini T; Gregis G; Lazzarin A; Esposito R; Moroni M
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):187-9. PubMed ID: 2060526
[TBL] [Abstract][Full Text] [Related]
13. Toxoplasmic encephalitis.
Luft BJ; Fuhrer J
AIDS Clin Rev; 1990; ():215-34. PubMed ID: 2083178
[No Abstract] [Full Text] [Related]
14. [Toxoplasmosis: new aspects, diagnosis and treatment].
Oksenhendler E; Matheron S
Rev Prat; 1992 Jan; 42(2):155-9. PubMed ID: 1565998
[TBL] [Abstract][Full Text] [Related]
15. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.
Katlama C; De Wit S; O'Doherty E; Van Glabeke M; Clumeck N
Clin Infect Dis; 1996 Feb; 22(2):268-75. PubMed ID: 8838183
[TBL] [Abstract][Full Text] [Related]
16. Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review.
Iaccheri B; Fiore T; Papadaki T; Androudi S; Janjua S; Bhaila I; Stephen Foster C
Clin Ther; 2008 Nov; 30(11):2069-74. PubMed ID: 19108794
[TBL] [Abstract][Full Text] [Related]
17. Toxoplasmic encephalitis.
Luft BJ; Hafner R
AIDS; 1990 Jun; 4(6):593-5. PubMed ID: 2386623
[No Abstract] [Full Text] [Related]
18. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
Schürmann D; Bergmann F; Albrecht H; Padberg J; Grünewald T; Behnsch M; Grobusch M; Vallée M; Wünsche T; Ruf B; Suttorp N
J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747
[TBL] [Abstract][Full Text] [Related]
19. [Encephalic toxoplasmosis in patients with the acquired immunodeficiency syndrome. A clinico-radiological study and the therapeutic results in 78 cases].
González-Clemente JM; Miró JM; Pedrol E; Alvarez R; Gatell JM; Mallolas J; Graus F; Mercader JM; Guelar A; Jiménez de Anta MT
Med Clin (Barc); 1990 Oct; 95(12):441-6. PubMed ID: 2084411
[TBL] [Abstract][Full Text] [Related]
20. Toxoplasmic encephalitis in acquired immunodeficiency syndrome.
Chaddha DS; Kalra SP; Singh AP; Gupta RM; Sanchetee PC
J Assoc Physicians India; 1999 Jul; 47(7):680-4. PubMed ID: 10778586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
